Literature DB >> 28495926

Mobilizing plasmacytoid dendritic cells.

Edmund K Waller1.   

Abstract

Mesh：

Year:  2017        PMID： 28495926      PMCID： PMC5428462          DOI： 10.1182/blood-2017-03-774703

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation.

Authors:  Michael Brave; Ann Farrell; Sue Ching Lin; Terrance Ocheltree; Sarah Pope Miksinski; Shwu-Luan Lee; Haleh Saber; Jeanne Fourie; Christoffer Tornoe; Brian Booth; Weishi Yuan; Kun He; Robert Justice; Richard Pazdur
Journal:  Oncology       Date:  2010-06-08       Impact factor: 2.935

Review 2.  Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells.

Authors:  Takashi Nagasawa; Yoshiki Omatsu; Tatsuki Sugiyama
Journal:  Trends Immunol       Date:  2011-04-29       Impact factor: 16.687

3.  Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.

Authors:  Mark A Schroeder; Michael P Rettig; Sandra Lopez; Stephanie Christ; Mark Fiala; William Eades; Fazia A Mir; Jin Shao; Kyle McFarland; Kathryn Trinkaus; William Shannon; Elena Deych; Jinsheng Yu; Ravi Vij; Keith Stockerl-Goldstein; Amanda F Cashen; Geoffrey L Uy; Camille N Abboud; Peter Westervelt; John F DiPersio
Journal:  Blood       Date:  2017-03-14       Impact factor: 22.113

4.  Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.

Authors:  Linda J Burns; Brent R Logan; Pintip Chitphakdithai; John P Miller; Rebecca Drexler; Stephen Spellman; Galen E Switzer; John R Wingard; Claudio Anasetti; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-21       Impact factor: 5.742

5.  Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.

Authors:  Edmund K Waller; Brent R Logan; Wayne A C Harris; Steven M Devine; David L Porter; Shin Mineishi; John M McCarty; Corina E Gonzalez; Thomas R Spitzer; Oleg I Krijanovski; Michael L Linenberger; Ann Woolfrey; Alan Howard; Juan Wu; Dennis L Confer; Claudio Anasetti
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

6.  Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation.

Authors:  E K Waller; H Rosenthal; T W Jones; J Peel; S Lonial; A Langston; I Redei; I Jurickova; M W Boyer
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

7.  Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.

Authors:  Hal E Broxmeyer; Christie M Orschell; D Wade Clapp; Giao Hangoc; Scott Cooper; P Artur Plett; W Conrad Liles; Xiaxin Li; Barbara Graham-Evans; Timothy B Campbell; Gary Calandra; Gary Bridger; David C Dale; Edward F Srour
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.